Cargando…
FARSB serves as a novel hypomethylated and immune cell infiltration related prognostic biomarker in hepatocellular carcinoma
Purpose: Hepatocellular carcinoma (HCC) is a prevalent tumor with high morbidity, and an unfavourable prognosis. FARSB is an aminoacyl tRNA synthase, and plays a key role in protein synthesis in cells. Furthermore, previous reports have indicated that FARSB is overexpressed in gastric tumor tissues...
Autores principales: | Zhen, Jing, Pan, Jingying, Zhou, Xuanrui, Yu, Zichuan, Jiang, Yike, Gong, Yiyang, Ding, Yongqi, Liu, Yue, Guo, Liangyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188347/ https://www.ncbi.nlm.nih.gov/pubmed/37074800 http://dx.doi.org/10.18632/aging.204619 |
Ejemplares similares
-
Biological function analysis of ARHGAP39 as an independent prognostic biomarker in hepatocellular carcinoma
por: Ding, Yongqi, et al.
Publicado: (2023) -
ZNF320 is a hypomethylated prognostic biomarker involved in immune infiltration of hepatocellular carcinoma and associated with cell cycle
por: Zhen, Jing, et al.
Publicado: (2022) -
Identification of KRBA1 as a Potential Prognostic Biomarker Associated with Immune Infiltration and m6A Modification in Hepatocellular Carcinoma
por: Liu, Yue, et al.
Publicado: (2022) -
Identified RP2 as a prognostic biomarker for glioma, facilitating glioma pathogenesis mainly via regulating tumor immunity
por: Gong, Yiyang, et al.
Publicado: (2023) -
ZNF765 is a prognostic biomarker of hepatocellular carcinoma associated with cell cycle, immune infiltration, m(6)A modification, and drug susceptibility
por: Ding, Yongqi, et al.
Publicado: (2023)